- Home
- PM vs AZN Comparison
PM vs AZN Comparison
Compare PM & AZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PM
- AZN
- Stock Information
- Founded
- PM 1987
- AZN 1992
- Country
- PM United States
- AZN United Kingdom
- Employees
- PM N/A
- AZN N/A
- Industry
- PM Medicinal Chemicals and Botanical Products
- AZN Biotechnology: Pharmaceutical Preparations
- Sector
- PM Health Care
- AZN Health Care
- Exchange
- PM Nasdaq
- AZN Nasdaq
- Market Cap
- PM 256.7B
- AZN 255.5B
- IPO Year
- PM N/A
- AZN 1993
- Fundamental
- Price
- PM $147.67
- AZN $82.01
- Analyst Decision
- PM Strong Buy
- AZN Strong Buy
- Analyst Count
- PM 9
- AZN 2
- Target Price
- PM $195.44
- AZN N/A
- AVG Volume (30 Days)
- PM 7.7M
- AZN 5.0M
- Earning Date
- PM 10-21-2025
- AZN 11-06-2025
- Dividend Yield
- PM 3.98%
- AZN 1.87%
- EPS Growth
- PM N/A
- AZN 28.86
- EPS
- PM 5.52
- AZN 5.31
- Revenue
- PM $39,992,000,000.00
- AZN $56,501,000,000.00
- Revenue This Year
- PM $10.72
- AZN $10.82
- Revenue Next Year
- PM $7.66
- AZN $5.99
- P/E Ratio
- PM $26.74
- AZN $15.45
- Revenue Growth
- PM 7.45
- AZN 15.00
- 52 Week Low
- PM $116.12
- AZN $61.24
- 52 Week High
- PM $186.69
- AZN $86.57
- Technical
- Relative Strength Index (RSI)
- PM 38.76
- AZN 47.84
- Support Level
- PM $142.11
- AZN $81.29
- Resistance Level
- PM $159.11
- AZN $84.22
- Average True Range (ATR)
- PM 3.99
- AZN 1.28
- MACD
- PM -0.83
- AZN -0.44
- Stochastic Oscillator
- PM 29.91
- AZN 32.45
About PM Philip Morris International Inc
Created from the international operations of Altria in 2008, Philip Morris International sells cigarettes and reduced-risk products, including heat sticks, vapes, and oral nicotine offerings, primarily outside of the US. With the 2023 acquisition of Swedish Match, a leading manufacturer of traditional oral tobacco products and nicotine pouches primarily in the US and Scandinavia, PMI has not only diversified away from smokable products but also gained a toehold in the US to sell its Iqos heated tobacco product.
About AZN AstraZeneca PLC
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.